B-Type Natriuretic Peptide Is Related to Left Ventricular Mass in Hypertensive Patients but Not in Athletes
- 1 November 2002
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 98 (3) , 113-115
- https://doi.org/10.1159/000066319
Abstract
A positive correlation has been previously documented between B-type natriuretic peptide (BNP) levels and left ventricular mass index (LVMI) in hypertensive patients. We evaluated 8 cycling athletes, 8 healthy age-matched controls; 17 hypertensive patients and 7 age-matched controls. LVMI was significantly higher in athletes and hypertensive patients than in their controls. Plasma levels of BNP in hypertensive patients were significantly higher than in athletes and their age-matched controls. No significant difference was found between athletes and their controls. Cycling athletes had significantly larger LVMI than hypertensive patients and controls, without elevated BNP levels. These results suggest that BNP levels are elevated in patients with increased LVM due to hypertension but not in physiologically increased LVM. Whether elevated BNP levels in athletes is a sign of structural heart disease merits further investigation.This publication has 6 references indexed in Scilit:
- Changes in cardiac markers including B-natriuretic peptide in runners after the Boston marathonThe American Journal of Cardiology, 2001
- Predictors of prognosis in patients with stable mild to moderate heart failureJournal of Cardiac Failure, 2000
- Left ventricular mass index and sports: the influence of different sports activities and arterial blood pressureInternational Journal of Cardiology, 2000
- Plasma brain natriuretic peptide in athletesThe American Journal of Cardiology, 2000
- Brain natriuretic peptide as a marker of cardiac involvement in hypertensionInternational Journal of Cardiology, 1999
- Biochemical detection of left-ventricular systolic dysfunctionThe Lancet, 1998